Ticker

Analyst Price Targets — HCM

Page 1 • Showing up to 10
DateAnalystFirmTargetPrice @ PostSourceHeadline
May 14, 2024 8:32 amJack LinMorgan Stanley$17.50$21.45StreetInsider Morgan Stanley Closes Research Tactical Idea on Hutchison China MediTech Ltd. (HCM)

Latest News for HCM

HUTCHMED (China) Limited Sponsored ADR $HCM Shares Sold by M&G PLC

M&G PLC cut its position in shares of HUTCHMED (China) Limited Sponsored ADR (NASDAQ: HCM) by 21.3% during the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 204,432 shares of the company's stock after selling 55,185 shares during the period. M&G

Defense World • Feb 18, 2026
HCM IV Acquisition Corp Announces Pricing of $250 Million Initial Public Offering

NORWALK, CT , Feb. 11, 2026 (GLOBE NEWSWIRE) -- HCM IV Acquisition Corp (the “Company”), a blank check company whose business purpose is to effect a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses, announced today that it has priced its initial public offering of 25,000,000 units at $10.00 per unit. Each unit consists…

GlobeNewsWire • Feb 11, 2026
HUTCHMED to Announce 2025 Final Results

HONG KONG and SHANGHAI and FLORHAM PARK, N.J., Feb. 06, 2026 (GLOBE NEWSWIRE) -- HUTCHMED (China) Limited (“HUTCHMED”) (Nasdaq/AIM: HCM; SEHK:13) will be announcing its final results for the year ended December 31, 2025 on Thursday, March 5, 2026 at 6:00 am Eastern Standard Time (EST) / 11:00 am Greenwich Mean Time (GMT) / 7:00 pm Hong Kong Time (HKT).

GlobeNewsWire • Feb 6, 2026

🧮 Earnings Move Analyzer

Insider Trading

No insider trades found for HCM.

No Senate trades found for HCM.

No House trades found for HCM.

Options Chain

Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.

Scroll to Top